Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.
Minkov M, Pötschger U, Thacker N, Astigarraga I, Braier J, Donadieu J, Henter JI, Lehrnbecher T, Rodriguez-Galindo C, Sieni E, Nanduri V, van den Bos C, Abla O; LCH Study Group of the Histiocyte Society. Minkov M, et al. J Pediatr. 2021 Oct;237:65-70.e3. doi: 10.1016/j.jpeds.2021.06.016. Epub 2021 Jun 17. J Pediatr. 2021. PMID: 34146548 Free article.
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J, Bernard F, van Noesel M, Barkaoui M, Bardet O, Mura R, Arico M, Piguet C, Gandemer V, Armari Alla C, Clausen N, Jeziorski E, Lambilliote A, Weitzman S, Henter JI, Van Den Bos C; Salvage Group of the Histiocyte Society. Donadieu J, et al. Blood. 2015 Sep 17;126(12):1415-23. doi: 10.1182/blood-2015-03-635151. Epub 2015 Jul 20. Blood. 2015. PMID: 26194764 Free PMC article. Clinical Trial.
Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood.
Aricò M, Astigarraga I, Braier J, Donadieu J, Gadner H, Glogova E, Grois N, Henter JI, Janka G, McClain KL, Ladisch S, Pötschger U, Rosso D, Thiem E, Weitzman S, Windebank K, Minkov M; Histiocyte Society. Aricò M, et al. Among authors: grois n. Br J Haematol. 2015 Apr;169(2):241-8. doi: 10.1111/bjh.13271. Epub 2014 Dec 18. Br J Haematol. 2015. PMID: 25522229 Free article.
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S; Histiocyte Society. Gadner H, et al. Among authors: grois n. Blood. 2013 Jun 20;121(25):5006-14. doi: 10.1182/blood-2012-09-455774. Epub 2013 Apr 15. Blood. 2013. PMID: 23589673 Free article. Clinical Trial.
A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, Komp D, Michaelis J, Nicholson S, Pötschger U, Pritchard J, Ladisch S; Histiocyte Society. Gadner H, et al. Among authors: grois n. J Pediatr. 2001 May;138(5):728-34. doi: 10.1067/mpd.2001.111331. J Pediatr. 2001. PMID: 11343051 Clinical Trial.
Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, Henter JI, Janka-Schaub G, Ladisch S, Ritter J, Steiner M, Unger E, Gadner H; DALHX- and LCH I and II Study Committee. Grois N, et al. Pediatr Blood Cancer. 2006 Feb;46(2):228-33. doi: 10.1002/pbc.20425. Pediatr Blood Cancer. 2006. PMID: 16047354
51 results